Completed PHASE3 NCT00343382

Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer

Pilocarpine for Vaginal Dryness: A Phase III Randomized, Double Blind, Placebo-Controlled Study

Sponsor: Alliance for Clinical Trials in Oncology

Conditions Breast Cancer Vaginal Dryness

Interventions pilocarpine hydrochloride placebo

Updated 7 times since 2017 Last updated: Jul 12, 2016 Started: Dec 31, 2006 Primary completion: Jul 31, 2009 Completion: Dec 31, 2012

Listed as NCT00343382, this PHASE3 trial focuses on Breast Cancer and Vaginal Dryness and remains completed. Sponsored by Alliance for Clinical Trials in Oncology, it has been updated 7 times since 2006, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Data source: Alliance for Clinical Trials in Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alexandria, United States , Allentown, United States , Ames, United States , Anderson, United States , Ann Arbor, United States , Aurora, United States , Battle Creek, United States , Bellefontaine, United States , Bemidji, United States , Bettendorf, United States and 115 more locations